Rubicon Research Secures INR 250 Cr Pre-IPO Boost From Amansa, Slashes Fresh Issue Size
In a pre-IPO placement ahead of its much-awaited public market debut, pharmaceutical formulations company Rubicon Research has raised INR 250 crore from Amansa Investments. The deal, finalised under a share purchase agreement dated 11 August and approved by Rubicon’s board on 12 August 2025, has changed the company’s IPO plans—reducing its fresh equity issue from […]
Rubicon Research Secures INR 250 Cr Pre-IPO Boost From Amansa, Slashes Fresh Issue Size Read More »









